XM does not provide services to residents of the United States of America.
F
F

FifthThird

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

U.S. Ardelyx, Eli Lilly, Tesla

U.S. RESEARCH ROUNDUP-Ardelyx, Eli Lilly, Tesla July 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Ardelyx, Eli Lilly and Tesla, on Wednesday. HIGHLIGHTS * Ardelyx Inc ARDX.O : Piper Sandler cuts to neutral from overweight * Eli Lilly LLY.N : Jefferies raises target price to $1,041 from $1,015 * Nicolet Bankshares Inc NIC.N : Stephens raises target price to $90 from $88 * Tesla Inc TSLA.O : Wedbush raises target
A
C
C
C
H
I
J
M
T
C
F
D
A
C
M

Big US banks withstand Fed's commercial real estate shock scenario

Big US banks withstand Fed's commercial real estate shock scenario By Michelle Conlin NEW YORK, June 26 (Reuters) - Big U.S. banks survived a hypothetical 40% drop in commercial real estate values as a part of the U.S. Federal Reserve's annual health test , easing fears about the banking sector as landlords struggle in a higher-for-longer interest rate world.
G
H
N
F
M

What are the Fed's bank 'stress tests' and what's new this year?

EXPLAINER-What are the Fed's bank 'stress tests' and what's new this year? By Pete Schroeder and Michelle Price WASHINGTON, June 24 (Reuters) - The U.S. Federal Reserve is due to release the results of its annual bank health checks on Wednesday at 4:30 p.m. ET (2030 GMT). Under the "stress test" exercise, the Fed tests big banks' balance sheets against a hypothetical scenario of a severe economic downturn, the elements of which change annually.
B
C
D
G
H
H
J
N
S
U
F
C
M

U.S. CarMax, Eli Lilly, MicroStrategy

U.S. RESEARCH ROUNDUP-CarMax, Eli Lilly, MicroStrategy June 24 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CarMax, Eli Lilly and MicroStrategy, on Monday. HIGHLIGHTS * CarMax Inc KMX.N : RBC raises target price to $75 from $73 * Eli Lilly LLY.N : Jefferies raises target price to $1,015 from $994 * MicroStrategy Inc MSTR.O : Canaccord Genuity cuts target price to $1,826 from $2,047 * Sharecare Inc SHCR.O : Canacco
A
A
B
D
G
M
N
V
E
F
T
E
P
R
T
C
C
I

U.S. STOCKS Tesla, Casey's General Store, Western Alliance

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Casey's General Store, Western Alliance Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stocks rose broadly on Wednesday, with the S&P 500 and the Nasdaq touching fresh record highs after softer inflation data lifted hopes for central bank rate cuts, while Apple overtook Microsoft to become the world's most valuable company.
A
B
D
G
M
P
R
T
F
T
T
U
U
E

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.